The biology of aging is increasingly understood as a set of modifiable processes rather than an inevitable decline. Longevity peptides like Epithalon and GHK-Cu target specific hallmarks of aging — from telomere shortening to epigenetic drift — offering new avenues for anti-aging research.
The Hallmarks of Aging
The 2013 Lopez-Otin framework identified nine hallmarks of aging: genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication. Longevity peptides target multiple of these hallmarks simultaneously.
Epithalon and Telomere Biology
Epithalon (Epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed by Prof. Vladimir Khavinson. It activates telomerase in human somatic cells. Telomere elongation has been demonstrated in vitro, and extended lifespan has been shown in multiple animal models. Epithalon also regulates melatonin production through the pineal gland.
GHK-Cu and Gene Regulation
GHK-Cu (copper peptide) is a naturally occurring tripeptide found in human plasma. Its plasma concentration declines from ~200 ng/mL at age 20 to ~80 ng/mL at age 60. Microarray studies show that GHK-Cu modulates the expression of 31.2% of the human genome — upregulating genes for tissue repair and antioxidant defense.
MOTS-c: The Mitochondrial Peptide
MOTS-c is encoded within the mitochondrial genome (12S rRNA), not the nuclear genome. It activates AMPK, the master metabolic regulator, and improves insulin sensitivity. Circulating MOTS-c levels decline with age, and supplementation in aging mice restored metabolic function and extended lifespan.
Practical Research Protocols
Epithalon is typically studied in cycles of 10 days on, followed by a 3–6 month rest period. GHK-Cu is used both systemically and topically for skin applications. Combining these peptides with lifestyle interventions such as caloric restriction and exercise may produce synergistic effects on longevity biomarkers.
FDA Disclaimer
The statements made within this website have not been evaluated by the US Food and Drug Administration. The information provided is not intended to diagnose, treat, cure, or prevent any disease. This website is intended for educational and research purposes only. Many peptides described on this site are not approved by the FDA for human therapeutic use and are classified as research chemicals. Nothing on this site constitutes medical advice.
